Martin F. Pera is at the Monash Institute of Medical Research, Monash University, and the Australian Stem Cell Centre, Victoria, Australia. martin.pera@med.monash.edu.au
Introducing inhibitors of bone morphogenic proteins along with basic fibroblast growth factor (bFGF) into culture medium for human embryonic stem (ES) cells facilitates long-term maintenance of these cells in the pluripotent state, coming one step closer to the goal of a fully defined system for human ES cell (hESC) culture free of animal products.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
